$0.9590
0.54128.33%
Last update: Oct 20, 4:00 PM
AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (ATXI) Stock Price, Quote, News & History
ATXIOTCID
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and...
You can purchase shares of AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (OTCID:ATXI) through any online brokerage.
There are no as such competitors for AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc..
AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. has a consensus price target of $56.25.
The stock price for AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (OTCID: ATXI) is $0.959 last updated October 20, 2025 at 4:00 PM EDT.
There are no upcoming dividends for AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc..
AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc..
AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCID.
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It is focused on advancing impactful therapies with the potential to...
